ALLO Announces FDA Clearance of the IND for ALLO-501 Viés de alta

Allogene Therapeutics, Inc.NASDAQ

Descrição

⋅ 28 de Jan de 2019 16:56

ALLO: Allogene Therapeutics, Inc.
2019-01-28 08:30:00
Allogene Therapeutics, in Collaboration with Servier, Announces FDA Clearance of the IND for ALLO-501, an anti-CD19 Allogeneic CAR T (AlloCAR T™) Therapy

Beyond Technical Analysis

Comentários

BasedDeptGeneral

⋅ 27 de Fev de 2019 09:17

This isn't an idea. You literally just typed some stuff, did no TA, and hit publish.

Mais